HealthEquity PE Ratio 2014-2024 | HQY
Current and historical p/e ratio for HealthEquity (HQY) from 2014 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. HealthEquity PE ratio as of April 24, 2024 is 50.77.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| HealthEquity PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-25 | 79.04 | 123.50 | |
| 2024-01-31 | 75.58 | $0.64 | 118.09 |
| 2023-10-31 | 71.68 | $0.34 | 210.82 |
| 2023-07-31 | 67.94 | $0.15 | 452.93 |
| 2023-04-30 | 53.45 | $-0.10 | 0.00 |
| 2023-01-31 | 60.85 | $-0.31 | 0.00 |
| 2022-10-31 | 77.91 | $-0.70 | 0.00 |
| 2022-07-31 | 58.17 | $-0.74 | 0.00 |
| 2022-04-30 | 62.32 | $-0.66 | 0.00 |
| 2022-01-31 | 53.44 | $-0.53 | 0.00 |
| 2021-10-31 | 66.18 | $-0.07 | 0.00 |
| 2021-07-31 | 73.98 | $0.01 | 7398.00 |
| 2021-04-30 | 75.97 | $0.06 | 1266.17 |
| 2021-01-31 | 83.55 | $0.12 | 696.25 |
| 2020-10-31 | 51.49 | $0.05 | 1029.80 |
| 2020-07-31 | 51.56 | $-0.27 | 0.00 |
| 2020-04-30 | 56.27 | $0.03 | 1875.67 |
| 2020-01-31 | 66.06 | $0.65 | 101.63 |
| 2019-10-31 | 56.79 | $0.86 | 66.03 |
| 2019-07-31 | 81.98 | $1.41 | 58.14 |
| 2019-04-30 | 67.75 | $1.47 | 46.09 |
| 2019-01-31 | 62.34 | $1.18 | 52.83 |
| 2018-10-31 | 91.80 | $1.06 | 86.60 |
| 2018-07-31 | 75.50 | $0.98 | 77.04 |
| 2018-04-30 | 65.67 | $0.89 | 73.79 |
| 2018-01-31 | 50.62 | $0.76 | 66.61 |
| 2017-10-31 | 50.22 | $0.74 | 67.86 |
| 2017-07-31 | 45.87 | $0.67 | 68.46 |
| 2017-04-30 | 45.52 | $0.54 | 84.30 |
| 2017-01-31 | 46.25 | $0.45 | 102.78 |
| 2016-10-31 | 33.23 | $0.43 | 77.28 |
| 2016-07-31 | 29.52 | $0.40 | 73.80 |
| 2016-04-30 | 25.15 | $0.34 | 73.97 |
| 2016-01-31 | 21.55 | $0.29 | 74.31 |
| 2015-10-31 | 32.71 | $0.26 | 125.81 |
| 2015-07-31 | 33.66 | $0.24 | 140.25 |
| 2015-04-30 | 26.21 | $0.23 | 113.96 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $6.795B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.048B | 15.56 |
| Cencora (COR) | United States | $47.467B | 18.94 |
| ICON (ICLR) | Ireland | $25.527B | 24.10 |
| DiDi Global (DIDIY) | China | $23.901B | 0.00 |
| Avantor (AVTR) | United States | $17.269B | 23.79 |
| Viatris (VTRS) | United States | $13.856B | 3.96 |
| CochLear (CHEOY) | $13.551B | 0.00 | |
| Revvity (RVTY) | United States | $12.684B | 22.08 |
| Charles River Laboratories (CRL) | United States | $12.333B | 22.48 |
| Medpace Holdings (MEDP) | United States | $12.318B | 40.53 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.750B | 0.00 |
| Natera (NTRA) | United States | $11.049B | 0.00 |
| Solventum (SOLV) | United States | $10.961B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| Bausch + Lomb (BLCO) | Canada | $5.236B | 20.14 |
| Organon (OGN) | United States | $4.783B | 4.63 |
| Doximity (DOCS) | United States | $4.461B | 33.21 |
| PACS (PACS) | United States | $3.596B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.228B | 30.00 |
| Sotera Health (SHC) | United States | $3.190B | 15.65 |
| Progyny (PGNY) | United States | $3.133B | 52.58 |
| Life Times (LTH) | United States | $2.882B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.749B | 139.20 |
| Premier (PINC) | United States | $2.531B | 9.26 |
| Teladoc Health (TDOC) | United States | $2.325B | 0.00 |
| Agilon Health (AGL) | United States | $2.191B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.167B | 7.01 |
| BrightSpring Health Services (BTSG) | United States | $1.845B | 0.00 |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| Establishment Labs Holdings (ESTA) | $1.344B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.328B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.776B | 8.03 |
| Embecta (EMBC) | United States | $0.627B | 4.14 |
| Auna S.A (AUNA) | Luxembourg | $0.558B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.542B | 0.00 |
| Enhabit (EHAB) | United States | $0.510B | 46.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.502B | 0.00 |
| LifeMD (LFMD) | United States | $0.450B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.423B | 0.00 |
| CareDx (CDNA) | United States | $0.413B | 0.00 |
| Beauty Health (SKIN) | United States | $0.389B | 0.00 |
| MultiPlan (MPLN) | United States | $0.375B | 0.00 |
| DocGo (DCGO) | United States | $0.367B | 58.67 |
| ModivCare (MODV) | United States | $0.353B | 4.68 |
| Sera Prognostics (SERA) | United States | $0.326B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.308B | 0.00 |
| Sharecare (SHCR) | United States | $0.277B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.145B | 0.00 |
| So-Young (SY) | China | $0.121B | 40.67 |
| Oncology Institute (TOI) | United States | $0.089B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.077B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |